Page last updated: 2024-11-07

2-acetylaminofluorene and Pulmonary Fibrosis

2-acetylaminofluorene has been researched along with Pulmonary Fibrosis in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
" As an example of the application of the HF method, data for liver neoplasms caused by long-term exposure of mice to 2-acetylaminofluorene and data for radiation pneumonitis and pulmonary fibrosis caused by long-term exposure of dogs to ionizing radiation are analyzed."3.66Method of analysis of monotone dose-response probabilities after long-term exposure to a toxicant. ( Scott, BR, 1982)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scott, BR1

Other Studies

1 other study available for 2-acetylaminofluorene and Pulmonary Fibrosis

ArticleYear
Method of analysis of monotone dose-response probabilities after long-term exposure to a toxicant.
    Health physics, 1982, Volume: 42, Issue:3

    Topics: 2-Acetylaminofluorene; Animals; Dogs; Dose-Response Relationship, Drug; Dose-Response Relationship,

1982